0.15Open0.15Pre Close0 Volume54 Open Interest20.50Strike Price0.00Turnover7904.75%IV12.78%PremiumNov 15, 2024Expiry Date0.00Intrinsic Value100Multiplier0DDays to Expiry0.15Extrinsic Value100Contract SizeAmericanOptions Type0.1557Delta0.1238Gamma122.07Leverage Ratio-354.3806Theta0.0000Rho19.01Eff Leverage0.0001Vega
Summit Therapeutics Stock Discussion
$Nxu Inc (NXU.US)$ grab some on your way out.
After the dual-antibody drug data from Summit Therapeutics (SMMT.US) defeated the "drug king", it was listed as Citigroup's preferred stock and the target price was raised.
No comment yet